Regulus Therapeutics Inc.

About Regulus Therapeutics Inc.

Regulus Therapeutics is a biopharmaceutical company specializing in discovering and developing microRNA-based therapeutics for diseases with high unmet medical needs. Its focus includes orphan kidney diseases like ADPKD, utilizing proprietary oligonucleotide technologies and extensive IP. The company advances drug candidates through preclinical and clinical stages, leveraging collaborations and a strong scientific platform to target complex diseases via gene regulation modulation.